History of the Procedure
Although the popularity of fat transplantation is a relatively recent development in plastic surgery, the concept of fat transfer is not new. As early as 1893, free fat autografts were used to fill a soft tissue defect. The use of autogenous abdominal fat to correct deficits in the malar area and chin was reported in 1909. Throughout the early part of the 20th century, attempts were made to correct other conditions, including hemifacial atrophy and breast defects, but modern fat grafting did not develop until the early 1980s with the popularity of liposuction.
Illouz reported the transfer of liposuction aspirate fat in 1984.[1] In 1986, Ellenbogen reported the use of free pearl fat autografts in a variety of atrophic and posttraumatic facial deficits.[2] With refinements in technique, fat grafting has become the procedure of choice for an array of problems, including facial scarring, lip augmentation, and facial rhytides (such as several otherwise difficult-to-address areas such as the nasolabial fold and glabellar furrows).
Problem
Methods of addressing wrinkles and lines range from excision and redraping of excess skin to methods of skin resurfacing including dermabrasion, laser ablation, and chemical peels. Each of these modalities has limitations. Implantation of a filler substance into a deficient area is another solution. Whereas facial resurfacing can be thought of as razing the mountains, use of an implantable substance fills in the valleys.[3] Many materials have been tried for the correction of soft tissue defects and deficits. However, the use of most of these substances has met with difficulties, including impermanence, foreign body reaction, unnatural texture, and possible disease transmission. In addition, most of the products currently available remain relatively expensive.
Some materials, such as silicone, have resulted in spectacular failures. Small volumes of liquid silicone formerly were used as free injections. Defects intentionally were undercorrected, since the ongoing soft tissue reaction created additional volume. However, the reaction of the host tissue led to late complications including chronic edema, lymphadenopathy, scarring, skin ulceration, skin thinning and discoloration, and siliconomas.
Collagen currently is used widely. Available collagen consists of purified bovine collagen. Zyderm is 95% type I collagen and 5% type III collagen. The addition of glutaraldehyde cross-linking (Zyplast) slows resorption; however, the substance nonetheless eventually is degraded by the host. While collagen works well for the correction of fine lines, results for deeper furrows are less impressive. The major drawback to the use of collagen is the short duration of the response. Within 3-6 months the collagen is resorbed completely, and the improvement is lost. Also, because the collagen is bovine-derived, pretesting for an allergic response is required. The test spot should be observed for 1 full month prior to treatment.
The Food and Drug Administration (FDA) approved Gore-Tex (solid polytetrafluoroethylene) for facial plastic surgery in 1993. The result is generally predictable because the substance is nonreactive, but the resulting feel of the tissue is somewhat unnatural. The substance is rigid and is not available in an injectable form. In addition, infection remains a potential problem because the substance is a foreign body. Because this substance does not become integrated into the host tissue, it is generally easy to remove.
Newer substances are being marketed. Sheets of human dermis (AlloDerm) are also available and produce a more natural result. Again, the form of this substance limits its use. Although it is derived from a human source and becomes revascularized by the host, it is not autogenous. Concerns about possible disease transmission have been expressed, although processing appears to control for this. A micronized form of human dermis has been available since 2000. While the semiliquid form of the substance gives it the versatility of collagen, the substance does not have the longevity of the sheet form. The major impediments to use of this substance remain the high cost and, although initially touted as a permanent solution, the substance is eventually degraded by the host.
Use of injectable poly-L-lactic acid (PLLA) has gained widespread popularity in Europe since its approval for cosmetic correction in 1999. PLLA is a synthetic polymer of lactic acid that is biodegradable, resorbable, and biocompatible. The large particle size of PLLA (40-63 µm) prevents it from being phagocytosed by macrophages, but it can still be used in needles as fine as 26–gauge (ga). The outcome in patients with a loss of facial volume and contours appears to be very good as judged by physicians and patients, with satisfaction rates reaching as high as 70% and 75%, respectively. One multicenter trial conducted by Laglenne and colleagues involving 110 patients reported minor adverse effects, with only 10% of patients experiencing nonspecific ecchymoses and no patients experiencing allergic reactions.[4] However, others have reported many cases of granulomas and inflammatory reactions, which are difficult to treat.
Hyaluronic acid (HA) is a carbohydrate polymer and one of the major components of the extracellular matrix. It is found extensively in neural, connective and epithelial tissues. Although pure HA is not biocompatible with dermal tissues, the cross-linked form is biocompatible. HA was initially extracted from cock combs but, possible allergic reactions limited its use.[5] This problem was overcome by the compound Restylane, which is produced from nonanimal cells through a process of fermentation and filtration.[6] A study conducted at 6 medical centers in the United States showed similar outcomes to Zyplast as a filler in wrinkles.[7] The FDA approved its use in 2003. Complications are usually related to local inflammatory responses.[7]
An ideal substance would be readily available, inexpensive, long-lasting, natural-feeling, and would not cause adverse immunologic reactions. Autologous tissue meets these requirements. Several types of tissue can be transferred. Fascia and dermis require longer scars for harvesting. Ideally, dermis can be harvested from the area of a previous incision, such as a cesarean delivery or abdominal scar, to avoid a new donor site defect. Strips of these tissues can be useful for larger areas and deeper defects but do not have the flexibility of a liquid or semiliquid substance. Fat can be harvested through inconspicuous stab incisions. The harvesting does not leave a defect, and the removal of fat is often desirable. Fat tissue is soft and feels natural. It can be introduced to correct various deficiencies, it is not immunogenic, and it is readily available and inexpensive.
Autologous fat transfer has been used for correction of facial scarring, including acne scars. Enhancement of facial volume also can be achieved for disease processes such as hemifacial atrophy and for patients with aesthetic concerns, such as those who request lip augmentation. Signs of facial aging also can be improved.[8] Rhytides that are too deep to be addressed by resurfacing modalities and areas poorly addressed by traditional lifting procedures (eg, nasolabial folds, glabellar creases, tear troughs) can be treated with grafted fat.
Etiology
Aging skin is characterized by decreased thickness, elasticity, and adherence to underlying tissue. In the epidermis, the number of melanocytes and Langerhans cells decreases. The rete pegs interconnecting the epidermis and dermis flatten, causing increased susceptibility to shear forces. The dermis atrophies as loss of ground substance, elastic fibers, and collagen occurs. Sun exposure leads to distinct damage to the skin. Elastosis (ie, deposition of thickened, irregular, partially degraded elastic fibers in the dermis) is characteristic of sun damage.
Cigarette smoking also is associated with changes in the skin. Posttraumatic scarring, acne, and the repetitive action of underlying muscle result in predictable histologic changes. Failure to properly evert skin edges during wound closure can result in a depressed scar. Repeated weight fluctuations can contribute to wrinkling. A genetic contribution also is present.
Presentation
Older patients may present for correction of specific areas or for overall facial rejuvenation. The anatomic areas not addressed by traditional rhytidectomy, auxiliary lifting procedures, or facial resurfacing often are ideal for fat grafting. Patients of all ages may present for facial enhancement; lip augmentation is the most common request. Often patients have obtained information from friends or media sources such as the Internet. Patient education and understanding are crucial to obtain optimal results. For information on aesthetic procedures, including news and CME activities, see Medscape’s Aesthetic Medicine Resource Center.
This procedure can be performed on an outpatient basis with local anesthesia. The preoperative consultation is crucial. By far, the most important part of the preoperative workup is an extensive discussion identifying areas to be treated. In addition, details of the procedure, postoperative care, expectations, and possible adverse outcomes should be discussed.
Photographic documentation is critical to planning and evaluation of this surgery. Lighting, angle, and expression should be standardized to allow for accurate delineation of detail and adequate comparison of preoperative and postoperative views. The patient should not wear makeup for preoperative or postoperative photographic documentation. Digital photography is useful for the patient to indicate areas of concern during the consultation. Photographs are also useful for postoperative comparisons.
Indications
Aging and scarring result in loss of subcutaneous tissue, which is amenable to replacement by fat grafting. Indications for fat grafting include correction of atrophy due to aging or scarring and enhancement of facial elements (eg, to provide a fuller, more voluptuous lip; to correct glabellar frown lines). Areas of the face not well treated by procedures such as rhytidectomy include nasolabial folds, glabellar creases, and tear troughs. Lip augmentation may improve the appearance of fine perioral lines and increase the amount of vermilion show.
Relevant Anatomy
Despite early views that fat is a relatively inert and isolated tissue, fat has been demonstrated to be a well-vascularized tissue with high metabolic activity. In addition to its structural role, fat tissue serves as a reservoir for energy storage. The number of fat cells generally is assumed to be stable after the completion of adolescent growth. Changes in the volume of fatty tissue relate to the size of the cells and their overall lipid content. Cells removed by liposuction or other surgical procedures do not regenerate. Cells shrink with overall weight loss and, in fact, may dedifferentiate. However, subsequent weight gain causes redifferentiation of the cells with an increase in volume.
Fat tissue consists of fat cells, which have thin cell membranes enmeshed in a fibrous network. Without the supporting fibers, the cells tend to collapse. An additional supporting network of connective tissue structure creates the lobules of fat, which can be observed grossly. Harvesting fat while maintaining as much supporting structure as possible preserves structural integrity of the tissue and helps the tissue retain bulk in the transplanted site. Almost any site can be used for harvesting; however, the abdomen is easily accessible, and stab incisions can be hidden within the umbilicus or in the hair-bearing skin of the pubic area.
Contraindications
Contraindications to fat grafting include the presence of any disease processes that adversely affect wound healing and poor overall health status of the individual.
The use of free fat grafting for the treatment of contour abnormalities resulting from breast biopsy or for breast augmentation is generally contraindicated. The grafted fat can cause both palpable nodules and calcifications, situations that may hinder a diagnosis of breast cancer or cause unnecessary intervention.
Almost all candidates have some fat for harvesting; however, some individuals are unwilling to have a procedure performed at a distant site.
Illouz YG. L'avenir de la reutilization de la graisse apres liposuccion. Rev Chir Esthet Lang Franc. 1984;9:36.
Ellenbogen R. Free autogenous pearl fat grafts in the face--a preliminary report of a rediscovered technique. Ann Plast Surg. Mar 1986;16(3):179-94. [Medline].
Warren RJ, Aston SJ, Mendelson BC. Face lift. Plast Reconstr Surg. Dec 2011;128(6):747e-64e. [Medline].
Laglenne S, Lalanne B, Laglenne B, Asius J. Un nouveau produit comblement des rides, entirement resorbable. Dermatologie. 2000;54:30-3.
Richter AW, Ryde EM, Zetterström EO. Non-immunogenicity of a purified sodium hyaluronate preparation in man. Int Arch Allergy Appl Immunol. 1979;59(1):45-8. [Medline].
Olenius M. The first clinical study using a new biodegradable implant for the treatment of lips, wrinkles, and folds. Aesthetic Plast Surg. Mar-Apr 1998;22(2):97-101. [Medline].
Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. Jun 2003;29(6):588-95. [Medline].
Clauser LC, Tieghi R, Galiè M, Carinci F. Structural fat grafting: facial volumetric restoration in complex reconstructive surgery. J Craniofac Surg. Sep 2011;22(5):1695-701. [Medline].
Niechajev I, Sevcuk O. Long-term results of fat transplantation: clinical and histologic studies. Plast Reconstr Surg. Sep 1994;94(3):496-506. [Medline].
Chajchir A, Benzaquen I, Moretti E. Comparative experimental study of autologous adipose tissue processed by different techniques. Aesthetic Plast Surg. Spring 1993;17(2):113-5. [Medline].
Botti G, Pascali M, Botti C, Bodog F, Cervelli V. A clinical trial in facial fat grafting: filtered and washed versus centrifuged fat. Plast Reconstr Surg. Jun 2011;127(6):2464-73. [Medline].
Kuran I, Tumerdem B. A new simple method used to prepare fat for injection. Aesthetic Plast Surg. Jan-Feb 2005;29(1):18-22; discussion 23. [Medline].
Gatti JE. Permanent lip augmentation with serial fat grafting. Ann Plast Surg. Apr 1999;42(4):376-80. [Medline].
Peer LA. Transplantation of Tissue. Baltimore: Lippincott Williams & Wilkins; 1959.
Moore JH Jr, Kolaczynski JW, Morales LM, et al. Viability of fat obtained by syringe suction lipectomy: effects of local anesthesia with lidocaine. Aesthetic Plast Surg. Jul-Aug 1995;19(4):335-9. [Medline].
Smahel J. Adipose tissue in plastic surgery. Ann Plast Surg. May 1986;16(5):444-53. [Medline].
Ersek RA. Transplantation of purified autologous fat: a 3-year follow-up is disappointing. Plast Reconstr Surg. Feb 1991;87(2):219-27; discussion 228. [Medline].
Cortese A, Savastano G, Felicetta L. Free fat transplantation for facial tissue augmentation. J Oral Maxillofac Surg. Feb 2000;58(2):164-9; discussion 169-70. [Medline].
Bertossi D, Zancanaro C, Trevisiol L, et al. Lipofilling of the lips: ultrastructural evaluation by transmission electron microscopy of injected adipose tissue. Arch Facial Plast Surg. Sep-Oct 2003;5(5):392-8. [Medline].
Coleman SR. Long-term survival of fat transplants: controlled demonstrations. Aesthetic Plast Surg. Sep-Oct 1995;19(5):421-5. [Medline].
Rigotti G, Marchi A, Galie M, et al. Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. Apr 15 2007;119(5):1409-22; discussion 1423-4. [Medline].
Klinger M, Marazzi M, Vigo D, et al. Fat injection for cases of severe burn outcomes: a new perspective of scar remodeling and reduction. Aesthetic Plast Surg. May 2008;32(3):465-9. [Medline].
Viard R, Bouguila J, Voulliaume D, Comparin JP, Dionyssopoulos A, Foyatier JL. [Fat grafting in facial burns sequelae.]. Ann Chir Plast Esthet. Jul 30 2011;[Medline].
Tholpady SS, Llull R, Ogle RC, et al. Adipose tissue: stem cells and beyond. Clin Plast Surg. Jan 2006;33(1):55-62, vi. [Medline].
Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. Dec 2002;13(12):4279-95. [Medline].
Brzoska M, Geiger H, Gauer S, et al. Epithelial differentiation of human adipose tissue-derived adult stem cells. Biochem Biophys Res Commun. Apr 29 2005;330(1):142-50. [Medline].
Ayhan M, Senen D, Adanali G, et al. Use of beta blockers for increasing survival of free fat grafts. Aesthetic Plast Surg. Sep-Oct 2001;25(5):338-42. [Medline].
Billings E Jr, May JW Jr. Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery. Plast Reconstr Surg. Feb 1989;83(2):368-81. [Medline].
Bosniak S, Cantisano-Zilkha M, Glavas IP. Nonanimal stabilized hyaluronic acid for lip augmentation and facial rhytid ablation. Arch Facial Plast Surg. Nov-Dec 2004;6(6):379-83. [Medline].
Bostwick John III. Augmentation Mammaplasty. Plastic and Reconstructive Breast Surgery. 2000;I:239-370 (343).
Carpaneda CA, Ribeiro MT. Percentage of graft viability versus injected volume in adipose autotransplants. Aesthetic Plast Surg. Winter 1994;18(1):17-9. [Medline].
Chajchir A, Benzaquen I. Fat-grafting injection for soft-tissue augmentation. Plast Reconstr Surg. Dec 1989;84(6):921-34; discussion 935. [Medline].
Coleman SR. Facial recontouring with lipostructure. Clin Plast Surg. Apr 1997;24(2):347-67. [Medline].
Kulkarni RK, Moore EG, Hegyeli AF, et al. Biodegradable poly(lactic acid) polymers. J Biomed Mater Res. May 1971;5(3):169-81. [Medline].
Kulkarni RK, Pani KC, Neuman C, et al. Polylactic acid for surgical implants. Arch Surg. Nov 1966;93(5):839-43. [Medline].
Montanana Vizcaino J, Baena Montilla P, et al. Complications of autografting fat obtained by liposuction. Plast Reconstr Surg. Apr 1990;85(4):638-9. [Medline].
Niechajev I. Lip enhancement: surgical alternatives and histologic aspects. Plast Reconstr Surg. Mar 2000;105(3):1173-83; discussion 1184-7. [Medline].
Rees TD, Aston SJ, Thorne CHM. Blepharoplasty and facialplasty (subheadings facial aging and morphologic changes). Plast Surg. 1990;3:2360-3.
Saylan Z. Facial fillers and their complications. Aesthetic Surg J. 2003;23:221-4.
Schuller-Petrovic S. Improving the aesthetic aspect of soft tissue defects on the face using autologous fat transplantation. Facial Plast Surg. Apr 1997;13(2):119-24. [Medline].
Sommer B, Sattler G. Current concepts of fat graft survival: histology of aspirated adipose tissue and review of the literature. Dermatol Surg. Dec 2000;26(12):1159-66. [Medline].
Vleggaar D. Facial volumetric correction with injectable poly-L-lactic acid. Dermatol Surg. Nov 2005;31(11 Pt 2):1511-7; discussion 1517-8. [Medline].
Yuksel E, Weinfeld AB, Cleek R, et al. Increased free fat-graft survival with the long-term, local delivery of insulin, insulin-like growth factor-I, and basic fibroblast growth factor by PLGA/PEG microspheres. Plast Reconstr Surg. Apr 2000;105(5):1712-20. [Medline].

